TOP stocks:

Apple

Shares of other companies:

FTI Consulting Inc

Journey Medical

Rent the Runway

Lumentum Holdings Inc

Teradata

Globus Medical

Brookfield Infrastructure Partners LP

CSW Industrials Inc

Signet Jewelers Ltd

Knight Transportation Inc

Forecast: (MRNA) for today April 25 & Weekly Forecast from 21 April to 27 April

Updated: April 25, 2024

Brief information about Moderna, Inc.

Ticker: MRNA

Sector: Healthcare

Closing price of the last trading day: $111.98

Last trading day: 03/11/2024

Analyst forecast price: $220.67

52-week high/low: $497.49 / $115.61

Shares of Moderna, Inc. are traded on the stock exchange under the ticker MRNA, marking their space in the competitive "Healthcare" sector. For stakeholders, tracking the dynamic price movement of MRNA is crucial for making informed investment decisions. In a market influenced by myriad factors, predicting the trajectory of these shares becomes both a challenge and a necessity. Predictive analytics and data-driven insights play a pivotal role in forecasting the performance of MRNA. The investors seeking up-to-date and accurate forecasts for Moderna, Inc. shares can turn to resources like Allforecast.com. The website stands out as a reliable tool offering real-time predictions, ensuring that investors are equipped with current and anticipated stock trends. On Allforecast.com, users gain access to a comprehensive analysis and predictions specifically tailored for MRNA, spanning varied timeframes - from the next day's anticipations to weekly, monthly, and yearly forecasts. The platform’s real-time updating mechanism ensures that the forecasted data aligns with the ongoing market trends and economic shifts, offering users actionable insights to optimize their investment strategies. The forecasts integrate a mix of qualitative and quantitative analyses, sector-specific trends within "Healthcare", and broader market dynamics to present a holistic view of MRNA's expected performance. By leveraging such precise and timely data, investors can strategize their moves, balancing risks and opportunities associated with Moderna, Inc.'s stocks. Navigating through the unpredictable terrains of the stock market requires actionable insights and timely data. Allforecast.com serves as a companion for investors eyeing MRNA, offering them a blend of accuracy and timeliness in predicting stock movements, aiding in informed and strategic investment choices.

Main Headquarters: Situated at 200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US, this location serves as the primary hub for all corporate activities.

Moderna's Current Market Value: As of our last update, it's pegged at $65 268 437 000, indicating its standing in the financial landscape.

Shares Overview: Currently, 397 760 000 shares of Moderna are actively traded and held by the public.

Last year's EBITDA (Earnings Before Interest, Taxes, and Depreciation) for Moderna stood at 16 553 000 000$. This figure provides insights into the company's operational profitability. With this positive EBITDA, Moderna showcases a favorable financial health.

The PE ratio according to the latest reporting is at around 4.644. P/E shows the investor how many years his investment in this business pays off. That is, investments in Moderna shares will pay off in about 5 years. This is not a very long term in terms of investment. Basically, you can invest in this company.

In addition to fundamental factors, stocks are influenced by many other factors. For example, it is worth monitoring all global forecasts for Moderna shares. Our service will help you with this, in which we collect all forecasts and build one consensus forecast from them.

Moderna stock forecast

When considering an investment in Moderna, prospective investors often seek insights on its long-term performance. Our platform consolidates the expert analyses and projections from renowned global analysts to offer a unified consensus forecast for 2024, 2025, 2026, 2027, and 2028.

With these forecasts at your disposal, you can address critical questions like:

What will be the price of one share of Moderna in the subsequent years including 2024, 2025, 2026, 2027, and 2028?

What consensus have the analysts reached regarding the future performance of Moderna stock?

Is Moderna stock a viable option for both short-term and long-term investment?

Is it prudent to sell or hold Moderna shares in 2024?

Is 2024 the opportune moment to buy Moderna stock, or is patience a more viable strategy?

What are the anticipated entry and exit points for investing in Moderna stock, according to expert forecasts?

It’s pivotal to remember that these forecasts are to be utilized as informational resources and not definitive investment advice. The final investment decision rests solely upon the investor, contingent on their risk tolerance, investment goals, and thorough analysis of Moderna.

Insight into Our Forecasting Process

Our forecasting methodology encompasses the aggregation of public and expert data on Moderna, coupled with a sophisticated algorithm that calculates a weighted average forecast while eliminating outliers. This ensures that our audience receives a refined and realistic projection of Moderna stock’s future performance.

Moderna Daily Share Price Forecast for One Month

Our team has meticulously gathered and analyzed forecasts from a diverse pool of analysts to present a consolidated average daily forecast for Moderna shares over the upcoming month. It’s essential to bear in mind that short-term predictions can often be subject to significant volatility, influenced by a myriad of dynamic, real-time market factors.

As you scroll, you’ll discover a detailed graph illustrating the consensus forecast for Moderna stocks over the next 30 days. The gray spectrum of the chart delineates the historical trajectory of the stock’s price, while the turquoise spectrum provides a visual representation of the anticipated price, inclusive of potential fluctuation ranges, offering insights into prospective market trends and stock behaviors.

In the dynamic world of stock trading, analysts and investors closely observe the projected highs and lows of Moderna shares. Our integrated forecast predicts a peak price of $119.44 in the forthcoming 30 days, indicating the zenith of the stock's potential performance. An encouraging revelation, denoting an upside potential of 6.66% from the current standing.

On the flip side, the stock might plummet to a minimum of $105.14 within the same period. A decline of 6.5% signals caution, nudging investors towards a more conservative stance.

Consequently, a fluctuation corridor emerges, with the stock’s resistance at $119.44 and support at $105.14, indicating the oscillating nature of Moderna’s stock over the one-month spectrum. These oscillations, while providing trading opportunities, should be navigated with adept knowledge and strategic foresight.

So, what’s the trajectory of Moderna amidst these projections? The nuances of stock trading and investment are encapsulated in the constant ebb and flow of the market, influenced by intrinsic and extrinsic factors. Hence, a comprehensive, nuanced understanding of market dynamics, coupled with real-time analytics, emerges as the cornerstone for maximizing ROI and mitigating risks.

The evolution of Moderna’s stock is akin to a narrative unfolding, shaped by myriad factors including market trends, economic indicators, and investor sentiment. Each fluctuation is a chapter of this narrative, offering insights, challenges, and opportunities to the discerning investor.

Evaluating the resilience of the support level is crucial in gauging the future trajectory of Moderna shares. The anticipation is that the price will hover near the support level for 2 days. The support level at $105.14 appears to be resilient. The likelihood of this support level being breached is minimal, indicating a phase of stability for Moderna stocks.

It’s imperative to remember the innate unpredictability of the stock market. The actual future value of Moderna shares is subject to variables beyond predictive analytics. Nonetheless, investors can expect the stock to oscillate within the defined optimistic and pessimistic target price brackets, offering both challenges and opportunities for strategic trading and investment.

Forecast table for 30 days
Date	Target	Pes.	Opt.	Vol., %
Mar 28	115.24	114.23	116.17	1.69
Mar 29	114.88	113.79	116.81	2.65
Mar 30	112.83	110.02	114.92	4.45
Mar 31	114.72	112.15	117.13	4.44
Apr 01	113.76	111.45	115.11	3.29
Apr 02	115.87	112.91	118.91	5.32
Apr 03	116.40	114.93	119.13	3.65
Apr 04	116.80	114.56	118.11	3.11
Apr 05	118.07	115.01	119.44	3.84
Apr 06	116.01	112.96	118.32	4.75
Apr 07	112.39	110.07	114.48	4.00
Apr 08	110.43	108.65	111.74	2.85
Apr 09	112.63	109.91	114.36	4.05
Apr 10	111.56	110.00	113.44	3.12
Apr 11	112.89	111.55	114.63	2.76
Apr 12	116.13	114.10	119.06	4.35
Apr 13	115.28	112.74	116.13	3.01
Apr 14	118.10	117.19	119.43	1.90
Apr 15	114.18	113.26	115.93	2.36
Apr 16	112.70	110.09	114.51	4.01
Apr 17	114.67	113.43	116.31	2.55
Apr 18	111.74	110.76	112.52	1.59
Apr 19	115.65	112.70	118.81	5.42
Apr 20	113.71	111.56	114.94	3.03
Apr 21	112.20	109.68	113.77	3.72
Apr 22	112.08	109.29	113.80	4.13
Apr 23	110.55	109.50	113.22	3.39
Apr 24	110.55	108.34	113.53	4.79
Apr 25	108.34	106.07	109.44	3.18
Apr 26	106.67	105.14	108.43	3.13

Moderna Stock Forecast 28 Mar.

Presumably, on 03/28/2024, the price of shares will be in the range of $114.23 - $116.17. A $1.94 range width can provide 1.69% volatility. The weighted average price of this range is at $115.24, which is $2.95 higher than the previous day's weighted average price.

Moderna Stock Forecast 29 Mar.

Presumably, on 03/29/2024, the price of shares will be in the range of $113.79 - $116.81. A $3.02 range width can provide 2.65% volatility. The weighted average price of this range is at $114.88, which is $0.36 lower than the previous day's weighted average price.

Moderna Stock Forecast 30 Mar.

Presumably, on 03/30/2024, the price of shares will be in the range of $110.02 - $114.92. A $4.90 range width can provide 4.45% volatility. The weighted average price of this range is at $112.83, which is $2.05 lower than the previous day's weighted average price.

Moderna Stock Forecast 31 Mar.

Presumably, on 03/31/2024, the price of shares will be in the range of $112.15 - $117.13. A $4.98 range width can provide 4.44% volatility. The weighted average price of this range is at $114.72, which is $1.90 higher than the previous day's weighted average price.

Moderna Stock Forecast 01 Apr.

Presumably, on 04/01/2024, the price of shares will be in the range of $111.45 - $115.11. A $3.66 range width can provide 3.29% volatility. The weighted average price of this range is at $113.76, which is $0.96 lower than the previous day's weighted average price.

Moderna Stock Forecast 02 Apr.

Presumably, on 04/02/2024, the price of shares will be in the range of $112.91 - $118.91. A $6.00 range width can provide 5.32% volatility. The weighted average price of this range is at $115.87, which is $2.11 higher than the previous day's weighted average price.

Moderna Stock Forecast 03 Apr.

Presumably, on 04/03/2024, the price of shares will be in the range of $114.93 - $119.13. A $4.20 range width can provide 3.65% volatility. The weighted average price of this range is at $116.40, which is $0.53 higher than the previous day's weighted average price.

Moderna Stock Forecast 04 Apr.

Presumably, on 04/04/2024, the price of shares will be in the range of $114.56 - $118.11. A $3.56 range width can provide 3.11% volatility. The weighted average price of this range is at $116.80, which is $0.41 higher than the previous day's weighted average price.

Moderna Stock Forecast 06 Apr.

Presumably, on 04/06/2024, the price of shares will be in the range of $112.96 - $118.32. A $5.36 range width can provide 4.75% volatility. The weighted average price of this range is at $116.01, which is $2.07 lower than the previous day's weighted average price.

Moderna Stock Forecast 07 Apr.

Presumably, on 04/07/2024, the price of shares will be in the range of $110.07 - $114.48. A $4.41 range width can provide 4.00% volatility. The weighted average price of this range is at $112.39, which is $3.61 lower than the previous day's weighted average price.

Moderna Stock Forecast 08 Apr.

Presumably, on 04/08/2024, the price of shares will be in the range of $108.65 - $111.74. A $3.09 range width can provide 2.85% volatility. The weighted average price of this range is at $110.43, which is $1.97 lower than the previous day's weighted average price.

Moderna Stock Forecast 09 Apr.

Presumably, on 04/09/2024, the price of shares will be in the range of $109.91 - $114.36. A $4.45 range width can provide 4.05% volatility. The weighted average price of this range is at $112.63, which is $2.20 higher than the previous day's weighted average price.

Moderna Stock Forecast 10 Apr.

Presumably, on 04/10/2024, the price of shares will be in the range of $110.00 - $113.44. A $3.44 range width can provide 3.12% volatility. The weighted average price of this range is at $111.56, which is $1.06 lower than the previous day's weighted average price.

Moderna Stock Forecast 11 Apr.

Presumably, on 04/11/2024, the price of shares will be in the range of $111.55 - $114.63. A $3.08 range width can provide 2.76% volatility. The weighted average price of this range is at $112.89, which is $1.33 higher than the previous day's weighted average price.

Moderna Stock Forecast 12 Apr.

Presumably, on 04/12/2024, the price of shares will be in the range of $114.10 - $119.06. A $4.96 range width can provide 4.35% volatility. The weighted average price of this range is at $116.13, which is $3.24 higher than the previous day's weighted average price.

Moderna Stock Forecast 13 Apr.

Presumably, on 04/13/2024, the price of shares will be in the range of $112.74 - $116.13. A $3.39 range width can provide 3.01% volatility. The weighted average price of this range is at $115.28, which is $0.85 lower than the previous day's weighted average price.

Moderna Stock Forecast 14 Apr.

Presumably, on 04/14/2024, the price of shares will be in the range of $117.19 - $119.43. A $2.23 range width can provide 1.90% volatility. The weighted average price of this range is at $118.10, which is $2.82 higher than the previous day's weighted average price.

Moderna Stock Forecast 15 Apr.

Presumably, on 04/15/2024, the price of shares will be in the range of $113.26 - $115.93. A $2.68 range width can provide 2.36% volatility. The weighted average price of this range is at $114.18, which is $3.93 lower than the previous day's weighted average price.

Moderna Stock Forecast 16 Apr.

Presumably, on 04/16/2024, the price of shares will be in the range of $110.09 - $114.51. A $4.42 range width can provide 4.01% volatility. The weighted average price of this range is at $112.70, which is $1.48 lower than the previous day's weighted average price.

Table of forecasts for 2024.
Month	Target	Pes.	Opt.	Vol., %
Apr.	120.35	116.12	122.94	5.55
May.	127.39	123.83	130.25	4.93
Jun.	126.93	122.93	132.18	7.00
Jul.	120.99	112.60	127.85	11.92
Aug.	117.72	111.26	121.43	8.38
Sep.	125.03	117.15	132.68	11.70
Oct.	122.56	117.59	124.87	5.83
Nov.	125.53	121.35	130.73	7.17
Dec.	121.13	116.00	125.60	7.64

Diving into a more comprehensive insight, the monthly consensus forecast is an instrumental resource for investors eyeing Moderna's performance metrics. These projections are meticulously curated, leveraging insights from renowned global analysts and offering a panoramic view of the anticipated stock behaviour for the current year and beyond.

In the mid-term analysis, forecasting accuracy enhances, attributed to the diminished influence of transient market fluctuations. For this year, the zenith of Moderna share’s value is anticipated to touch $132.68, offering a robust metric for investment strategies, sans the extremes of varied agency forecasts.

On the contrary, the nadir projections settle at $111.26, delineating the lower threshold and offering a holistic perspective on the risk and return landscape.

Explore Detailed 2024 Forecast

Progressing further, we have extrapolated these analytical insights to generate consensus forecasts for subsequent years. The synthesized data, presented in intuitive tabular formats, offers investors, analysts, and enthusiasts a streamlined view into the future of Moderna stocks.

Anticipated Trends: Moderna (MRNA) Monthly Stock Trajectory for 2025

Table of forecasts for 2025.
Month	Target	Pes.	Opt.	Vol., %
Jan	121.67	116.09	130.10	10.77
Feb	123.10	118.77	131.52	9.69
Mar	115.56	112.23	118.27	5.10
Apr	123.57	117.68	128.91	8.71
May	128.91	120.90	135.52	10.79
Jun	123.80	121.35	127.48	4.81
Jul	134.05	127.54	137.19	7.04
Aug	129.23	121.44	131.56	7.69
Sep	131.44	126.71	138.89	8.77
Oct	127.06	124.32	132.89	6.45
Nov	129.46	122.24	138.09	11.48
Dec	132.03	125.73	136.66	8.00

Detailed forecast for 2025

Moderna (MRNA) Monthly Stock Prediction for 2026

Table of forecasts for 2026.
Month	Target	Pes.	Opt.	Vol., %
Jan	127.04	121.55	133.32	8.83
Feb	119.38	114.76	124.10	7.53
Mar	124.64	121.39	129.69	6.40
Apr	129.35	126.21	133.66	5.57
May	130.87	128.51	135.93	5.46
Jun	127.21	118.86	130.76	9.11
Jul	131.79	122.66	137.13	10.55
Aug	122.90	115.71	127.87	9.51
Sep	112.83	107.45	119.33	9.96
Oct	114.25	108.08	117.54	8.05
Nov	109.32	103.51	111.88	7.48
Dec	104.40	101.02	107.59	6.11

Detailed forecast for 2026

Moderna (MRNA) Monthly Stock Prediction for 2027

Table of forecasts for 2027.
Month	Target	Pes.	Opt.	Vol., %
Jan	102.90	96.69	108.36	10.77
Feb	112.16	107.92	118.82	9.18
Mar	117.61	110.41	120.04	8.02
Apr	126.39	123.55	135.49	8.82
May	126.96	118.28	130.16	9.13
Jun	126.39	119.79	133.10	10.00
Jul	128.55	124.73	135.26	7.78
Aug	132.37	129.99	137.49	5.46
Sep	130.70	126.00	139.05	9.39
Oct	136.35	133.16	143.34	7.11
Nov	146.90	143.46	152.85	6.14
Dec	156.29	149.54	163.18	8.36

Detailed forecast for 2027

Moderna (MRNA) Monthly Stock Prediction for 2028

Table of forecasts for 2028.
Month	Target	Pes.	Opt.	Vol., %
Jan	162.34	156.20	169.79	8.00
Feb	162.48	151.37	170.67	11.31
Mar	163.65	157.47	171.61	8.24
Apr	165.27	156.50	171.67	8.84
May	173.60	163.91	182.66	10.26
Jun	180.79	171.84	184.04	6.63
Jul	165.17	158.18	174.24	9.21
Aug	167.55	158.20	171.32	7.66
Sep	161.82	153.95	167.06	7.85
Oct	158.47	151.76	162.89	6.83
Nov	154.76	148.35	159.77	7.15
Dec	156.29	146.59	161.50	9.23

Detailed forecast for 2028

Stocks from the same sector (Healthcare)

Biogen Inc. (BIIB)

CVS Health Corp. (CVS)

Eargo, Inc. (EAR)

Novo Nordisk A/S (NVO)

Exelixis, Inc. (EXEL)

BioCryst Pharmaceuticals, Inc. (BCRX)

Teva Pharmaceutical Industries Lim. (TEVA) (TEVA)

Aadi Bioscience, Inc. (AADI)

Novavax, Inc. (NVAX)

Vallon Pharmaceuticals, Inc. (VLON)

Other securities

Occidental Petroleum

Applied Materials

Flowers Foods Inc

Truist Financial Corp

nCino

Ceridian HCM Holding Inc

RLX Technology

Eagle Materials Inc

Invesco Plc

Janus Henderson Group PLC

Denial of responsibility:

All submitted consensus forecasts are exposed to get acquainted with the algorithm for collecting forecasts and bringing them to a single whole. The portal allforecast.com is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.